AbbVie Inc cut its full-year profit forecast on Thursday, citing $280 million in milestone and in-process research and development expenses during the second quarter.
The company now expects adjusted profit between $10.57 and $10.97 per share, compared with $10.72 to $11.12 it previously expected.
Analysts on average were expecting full-year earnings of $10.97 per share, according to Refinitiv IBES data.
AbbVie also trimmed adjusted profit for the second quarter by $0.15 per share and expects to post adjusted profit of $2.75 to $2.85 per share.
The company is scheduled to report second-quarter results on July 27.
https://finance.yahoo.com/news/1-abbvie-trims-full-profit-210238702.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.